One of the most frequent statements, provided in different variations in the introduction of
experimental studies on multiple sclerosis (MS), is that “Multiple sclerosis is a demyelinating …

Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative
disease that affects the central nervous system (CNS). MS is characterized by immune …

Multiple sclerosis (MS), and its animal model experimental autoimmune encephalomyelitis,
are neuroinflammatory diseases driven by autoreactive pathogenic TH cells that elicit …

Multiple sclerosis (MS) is a disease of the central nervous system (CNS) characterized by
inflammatory, demyelinating lesions localized in the brain and spinal cord. Experimental …

Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous
system with an autoimmune attack on the components of the myelin sheath and axons. The …

Background Macrophages play a dual role in multiple sclerosis (MS) pathology. They can
exert neuroprotective and growth promoting effects but also contribute to tissue damage by …

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS).
Microglia are the resident innate immune cells in the CNS; they play an important role in the …

Microglia and infiltrating macrophages are thought to orchestrate the central nervous system
(CNS) response to injury; however, the similarities between these cells make it challenging …

The most frequent variant of multiple sclerosis (MS) is the relapsing–remitting form,
characterized by symptomatic phases followed by periods of total/partial recovery. Hence, it …

Multiple sclerosis (MS) is considered to be a T cell-mediated autoimmune disease that
results in the presence of inflammatory lesions/plaques associated with mononuclear cell …